H.C. Wainwright & Co., LLC

We are pleased to have served as Lead Manager for Crinetics Pharmaceuticals’ $500 Million Upsized Follow-On offering. Learn more about H.C. Wainwright and see all of our transactions online at www.hcwco.com/transactions

We extend our gratitude to all who participated in our annual Viral Hepatitis Conference yesterday. Our agenda featured esteemed KOLs, insightful company presentations, and enriching fireside chats—all of which contributed to a meaningful exchange of ideas surrounding the viral hepatitis treatment landscape. To be a part of future conferences, please visit www.hcwevents.com.

A huge thank you to all who participated at our MASH Investor Conference yesterday where we delved into the current landscape and the future of the Metabolic Dysfunction-Associated Steatohepatitis therapeutic space through various discussions featuring KOLs, company presentations, fireside chats, and meetings. Your active participation and insights truly enriched our conversations, making the event both productive and inspiring. We look forward to continuing the dialogue together! Check out our upcoming therapeutics conferences at www.hcwevents.com

Another Biotech on Tap in the books! Thank you to all attendees who joined us this week at the 5th Annual Biotech on Tap at Oktoberfest. It was an insightful and network filled week in Munich discussing the U.S. and EU markets, M&A, IPOs, Artificial Intelligence, and the Biotech sector.   A special shout to our co-host Goodwin as well as our sponsors CFGI, EY, NautaDutilh, and Toppan Merrill. We're in the process of planning Biotech on Tap 2025! If you have any ideas or would like an invitation, please reach out to Thomas Hoffmann, Dirk Gallowsky, or Robert Puopolo. Prost!

We invite you to join us on October 8th at the 5th Annual Viral Hepatitis Virtual Conference to engage in an in-depth exploration of the various viruses responsible for hepatitis, along with discussions on emerging technologies in the field. Join esteemed industry thought leaders as they share their insights and emerging advancements, contributing to combating viral hepatitis.   For more information and registration, visit https://lnkd.in/ehDKx6xJ

Join us at our 8th Annual MASH Investor Conference on October 7th to discuss metabolic dysfunction-associated steatohepatitis. The virtual conference will feature experts in gastroenterology, hepatology, and metabolism to discuss latest research, advancements, and clinical strategies regarding #MASH. Don’t miss this opportunity to expand your knowledge and connect with peers! Register here https://lnkd.in/eJkAPSm8

Next week, Richard Gormley, Michael E. Meyers, and Thomas Hoffmann will be in Munich, Germany to host our 5th annual Biotech on Tap during Oktoberfest. We are looking forward to connecting with over 150 industry leaders September 25-27th to discuss U.S. and international capital market trends and opportunities through various panels keynote speakers, and networking.                If interested in attending, please contact your HCW representative or email corporateaccess@hcwco.com

That’s a wrap on the 2024 HCW Global Investment Conference in New York! We welcomed over 2,000 guests including company executives across various sectors, institutional investors, and keynote speakers and were able to help facilitate over 4,000 meetings. Among the many conversations that occurred over the course of three-days, what was abundantly clear was the excitement for new emerging technologies and advancements across all subsectors. This enthusiasm creates opportunities for capital deployment and strategic partnerships, as market dynamics offer new avenues for growth and value creation. Thank you to all attendees, presenters, panelists, and our sponsors: Baker McKenzie, EisnerAmper, Ellenoff Grossman & Schole LLP, Haynes and Boone, LLP, IRTH Communications, Katten Muchin Rosenman LLP, Lowenstein Sandler LLP, Marcum LLP, and Sheppard Mullin Richter & Hampton LLP. We are immensely grateful for your continued support and contributions to another successful event. We can’t wait for next year! #HCWainwrightGlobal

CleanSpark (NASDAQ: CLSK) will be featured on the next HCW @ Home on September 23rd at 4pm ET for a virtual fireside chat. CleanSpark Chief Executive Officer, Zachary Bradford, and Executive Chairman, Matthew Schultz, will be joined by our Research Analyst, Mike Colonnese, for a discussion surrounding the company’s Bitcoin mining operations, growth strategy, recent acquisitions, the M&A landscape, as well as management’s near-term outlook for Bitcoin and the industry. To tune in, please register at https://ct.to/ykz8hN1

The 26th Annual Global Investment Conference kicked off with an opening address by our very own, Richard Gormley, Vice Chairman- President of Capital Markets welcoming attendees and providing an update on the Life Sciences capital markets. Over the course of the next three days, more than 500 companies and 2,000 attendees from around the globe will come together to share insights, forge new connections, and explore the future of Life Sciences, Cryptocurrency, Metals & Mining, Technology, Telecommunications, and Cleantech.   Today's highlights include: -Implications of New Healthcare Policy Reform on the Pharma/Biotech Industries Panel -Cutting-edge Approaches to Viral Hepatitis: Is a Cure on the Horizon? -Keynote by Vivek Ramaswamy, Former 2024 U.S. Presidential Candidate, New York Times Bestselling Author   If you’re in attendance, please connect with us and use the #HCWainwrightGlobal hashtag with conference associated posts! Our team can’t wait to engage with participants. Stay tuned!